USFDA completes inspection at Neuland Laboratories’ Hyderabad facility

24 Jun 2019 Evaluate

The United States Food and Drug Administration (USFDA) has completed inspection Neuland Laboratories' Unit 1 manufacturing facility at Bonthapally, Hyderabad. The inspection was conducted from June 17 to 21, 2019.

The inspection has been completed with five observations given under form 483. The company has already initiated corrective and preventive actions for the observations and is confident of satisfying the FDA within the stipulated time.

Neuland Laboratories manufactures active pharmaceutical ingredients for global pharmaceutical companies and provides end-to-end solutions for the pharmaceutical industry for chemistry-related services.

Neuland Laboratories Share Price

15200.00 9.75 (0.06%)
01-Jan-2026 14:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1718.85
Dr. Reddys Lab 1250.85
Cipla 1499.55
Zydus Lifesciences 912.30
Lupin 2099.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×